NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Apellis Pharmaceuticals (APLS) Technical (Analysis) Reports Apellis Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Apellis Pharmaceuticals (APLS)

Technical Analysis Report for NASDAQ stock APLS Apellis Pharmaceuticals. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock APLS Apellis Pharmaceuticals then click here. or read Experts views on Apellis Pharmaceuticals or Forecast & share price targets of Apellis Pharmaceuticals

Apellis Pharmaceuticals Opened at 22.68 and Closed at: 23.49, which is 3.96% of previous session's close. It moved within a range of 22.57 and 23.58
The session was a Bullish session with an average volume of 1824900, which is -61.26% of previous session's volumes.

• Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
• The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
• The stock has shown an up move, and its long term trend is also positive and in an uptrend.

A Golden cross was found 2 days back on short term averages

Support for tomorrow is 23.03 and resistance for tomorrow is 24.04
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 22.85, 22.2 resistance for tomorrow's hourly charts is 23.86, 24.22

10 Day SMA for Apellis Pharmaceuticals (APLS) is 22.78 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Apellis Pharmaceuticals (APLS) is 22.28 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Apellis Pharmaceuticals (APLS) is 23.37 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 23.28 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Apellis Pharmaceuticals is 22.12 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Apellis Pharmaceuticals is at 22.28 and 200 DMA is at 22.12, while 50 DMA and 100 DMA are at 23.37 and 23.28 respectively

Apellis Pharmaceuticals (APLS) moving average of 20 SMA is at 22.28 and 20 EMA is at 22.83

Apellis Pharmaceuticals (APLS) moving average of 50 SMA is at 23.37 and 50 EMA is at 23.08

Apellis Pharmaceuticals (APLS) moving average of 100 SMA is at 23.28 and 100 EMA is at 23.19

Apellis Pharmaceuticals (APLS) moving average of 200 SMA is at 22.12 and 200 EMA is at 23.94

Zai Lab has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Zai Lab, about 11.03% more returns!

111 Inc has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in 111 Inc, about 154.25% more returns!

Apellis Pharmaceuticals has performed better than Sintx Technologies in short term. Holding Apellis Pharmaceuticals could be a better choice for now!

Rhythm Pharmaceuticals has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 16.55% more returns!

Replimune Group has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Replimune Group, about 10.5% more returns!

Prothena Corporation has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Prothena Corporation, about 10.94% more returns!

Pacira Pharmaceuticals has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Pacira Pharmaceuticals, about 3.24% more returns!

Pavmed Inc has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Pavmed Inc, about 65.16% more returns!

Acadia Healthcare has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Acadia Healthcare, about 12.81% more returns!

Anixa Biosciences has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Anixa Biosciences, about 1.56% more returns!

Cellectar Biosciences has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Cellectar Biosciences, about 12.69% more returns!

Cytosorbents Corporation has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Cytosorbents Corporation, about 13.99% more returns!

Edap Tms has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Edap Tms, about 42.52% more returns!

Establishment Labs has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Establishment Labs, about 14.65% more returns!

Fortress Biotech has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Fortress Biotech, about 30.28% more returns!

Apellis Pharmaceuticals has performed better than Galmed Pharmaceuticals in short term. Holding Apellis Pharmaceuticals could be a better choice for now!

Hutchison China has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Hutchison China, about 17.11% more returns!

Apellis Pharmaceuticals has performed better than Hoth Therapeutics in short term. Holding Apellis Pharmaceuticals could be a better choice for now!

Immucell Corporation has performed better than Apellis Pharmaceuticals in short term. You could have earned much better returns by investing in Immucell Corporation, about 9.99% more returns!

Apellis Pharmaceuticals Technical analysis of indicators

Price action analysis of Apellis Pharmaceuticals (APLS) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

ADX buy sell signal for Apellis Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Apellis Pharmaceuticals in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Apellis Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

CCI has generated a buy signal for Apellis Pharmaceuticals in short term and BUY signal is strong.

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Apellis Pharmaceuticals is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 22.76 and Apellis Pharmaceuticals APLS stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Apellis Pharmaceuticals APLS stock. Volume based technical analysis of Apellis Pharmaceuticals APLS stock is negative.

Apellis Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock APLS Apellis Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And APLS Experts View which covers a lot of information including buying and selling signals

APLS future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Apellis Pharmaceuticals or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet